Teva’s accession to the exclusive group that is the Pharma Top 10 is further proof, according to IMS Health, that branded pharma needs to renounce its product-protected past and embrace the patient-led, specialty-focused future.
As the first non-western, non-innovative-core company to enter pharma’s global Top 10, according to IMS Health research, Teva’s rise to prominence [...]
PharmExec Blog
Follow Us
RSS
Bookstore
Teva Joins Top 10, “Face” of Big Pharma Changing